Cepheid Posts 24 Percent Revenue Growth for Q1 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market Thursday that its first-quarter revenues increased 24 percent with strong sales coming from both its systems and reagents and disposables.

The Sunnyvale, Calif.-based molecular diagnostics firm reported total revenues of $48 million for the three-month period ended March 31 compared to $38.8 million for the first quarter of 2009. Its results beat analysts' consensus estimate for the quarter of $45.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.